ACCOLADE: ACHIEVING GROWTH THROUGH PERSONALIZED HE
Post# of 3
$ACCD
Accolade, Inc. (NASDAQ: ACCD) is a personalized healthcare Company that provides personal, data-driven, and value-based healthcare solutions.
For FY24, Accolade's revenues were $414.3 million, up 14% year over year. It is targeting $1 bn in revenue and 15-20% Adjusted EBITDA in 5 years, which makes it an interesting watch.
Read on to know more:
Read on to know more:
https://www.aviseanalytics.com/accolade-achie...healthcare